METTL14 and neoplasm: These observations confirmed that ZFP14 served as both a novel target for METTL14‐mediated m6A modification and a significant tumour suppressor in ccRCC, shedding light on the cellular and molecular operations in ccRCC and opening up possibilities for novel therapeutic strategies.